Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-023279-25Phase 2Active
Phase 2 trial of cholecalciferol in graft-versus-host disease (GVHD), sponsored by José Antonio Pérez Simón. Primary endpoint: Incidence and severity of graft-versus-host disease. Started Jan 2011; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-023279-25.